After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

Tri-City Cardiology, a Phoenix-based cardiology group among the largest and most respected in the country, has expanded its ...

I felt fine, but my Whoop data told a different story. Paying attention led to early detection and a successful treatment.

Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and there is much to ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

The latest update is out from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ). Imricor Medical Systems has ...

Blues Traveler frontman John Popper has had his share of health issues through the years, but what he faced in 2025 … well, the singer told Rolling Stone that it nearly killed him. And the way he got ...

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...

Milestone Pharmaceuticals Inc.’s CARDAMYST nasal spray wins FDA approval for PSVT, but faces tough competition and market ...

Trigeminal neuralgia (TN) is a debilitating, chronic syndrome that causes sudden, severe, electric shock-like pain in the face. While TN isn’t life-threatening, it can severely alter quality of life ...

Abbott received approval from the Food and Drug Administration for its Volt Pulsed Field Ablation System to treat atrial fibrillation. The medical technology company said Monday that it would soon ...